VIATRIS INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
VIATRIS INC. (VTRS) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-08-06
- VIATRIS INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- VIATRIS INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-09-30 was $0.00.
- VIATRIS INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-06-30 was $2.20M, a 97.84% decline year-over-year.
- VIATRIS INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-09-30 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month as first filed | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2026-08-06 | $2.20M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $2.20M 10-Q · filed 2026-08-06 | $2.20M 10-Q · filed 2026-08-06 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $102.00M derived: sum of 2 quarters · filed 2025-11-06 | $102.00M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $102.00M 10-Q · filed 2025-08-07 | $102.00M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $32.00M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $32.00M 10-Q · filed 2023-08-07 | ||
| 2023-03-31 | $32.00M 10-Q · filed 2024-05-09 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $83.40M 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $83.40M 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $83.40M 10-Q · filed 2022-05-09 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |